CMA function becomes impaired during atherosclerosis progression, leading to increases in NLRP3 inflammasome activation and IL-1β secretion, boosting vascular inflammation and atherosclerosis progression (Qiao et al., 2021). This evidence concerns the gene NLRP3 and atherosclerosis.